Skip to Content

NZ (Iclusig 10 mg)

Generic Name: ponatinib

Pill with imprint NZ is White, Elliptical / Oval and has been identified as Iclusig 10 mg. It is supplied by Takeda Pharmaceuticals U.S.A., Inc..

Iclusig is used in the treatment of chronic myelogenous leukemia; acute lymphoblastic leukemia and belongs to the drug classes BCR-ABL tyrosine kinase inhibitors, multikinase inhibitors, VEGF/VEGFR inhibitors. There is positive evidence of human fetal risk during pregnancy. Iclusig 10 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for NZ

Iclusig

Generic Name
ponatinib
Imprint
NZ
Strength
10 mg
Color
White
Shape
Elliptical / Oval
Availability
Prescription only
Drug Class
Bcr-abl tyrosine kinase inhibitors, Multikinase inhibitors, Vegf/vegfr inhibitors
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
Takeda Pharmaceuticals U.S.A., Inc.
National Drug Code (NDC)
63020-0536

Get help with Imprint Code FAQs.

Related Images for "NZ"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.